Robeco Institutional Asset Management B.V. Sells 6,786 Shares of CME Group Inc. (NASDAQ:CME)

Robeco Institutional Asset Management B.V. lowered its position in CME Group Inc. (NASDAQ:CME - Free Report) by 4.3% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 151,547 shares of the financial services provider's stock after selling 6,786 shares during the period. Robeco Institutional Asset Management B.V.'s holdings in CME Group were worth $33,439,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Capital International Investors raised its holdings in shares of CME Group by 24.1% in the 1st quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider's stock worth $3,403,557,000 after acquiring an additional 3,069,806 shares during the last quarter. PineStone Asset Management Inc. raised its stake in shares of CME Group by 137.6% in the second quarter. PineStone Asset Management Inc. now owns 2,260,644 shares of the financial services provider's stock worth $444,443,000 after purchasing an additional 1,309,097 shares during the last quarter. M&G Plc purchased a new stake in shares of CME Group in the first quarter worth approximately $156,631,000. Assenagon Asset Management S.A. lifted its holdings in shares of CME Group by 577.9% in the second quarter. Assenagon Asset Management S.A. now owns 645,330 shares of the financial services provider's stock valued at $126,872,000 after purchasing an additional 550,133 shares in the last quarter. Finally, Ameriprise Financial Inc. boosted its position in shares of CME Group by 11.3% during the second quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider's stock valued at $1,038,676,000 after buying an additional 537,758 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company's stock.

Analyst Ratings Changes

A number of equities research analysts recently commented on CME shares. Citigroup increased their price target on CME Group from $250.00 to $255.00 and gave the company a "buy" rating in a research report on Thursday, October 24th. Royal Bank of Canada reiterated a "sector perform" rating and issued a $235.00 target price on shares of CME Group in a report on Thursday, October 24th. Bank of America raised their price target on shares of CME Group from $177.00 to $180.00 and gave the company an "underperform" rating in a research report on Thursday, October 3rd. Piper Sandler upped their price objective on shares of CME Group from $240.00 to $250.00 and gave the stock an "overweight" rating in a research report on Monday, October 28th. Finally, TD Cowen assumed coverage on shares of CME Group in a research report on Thursday, September 26th. They set a "hold" rating and a $221.00 target price on the stock. Four analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have given a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus price target of $222.73.

Insider Activity

In related news, insider Timothy Francis Mccourt sold 1,374 shares of CME Group stock in a transaction on Monday, October 28th. The stock was sold at an average price of $227.12, for a total transaction of $312,062.88. Following the completion of the sale, the insider now owns 7,275 shares of the company's stock, valued at approximately $1,652,298. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, insider Timothy Francis Mccourt sold 1,374 shares of the stock in a transaction on Monday, October 28th. The shares were sold at an average price of $227.12, for a total value of $312,062.88. Following the transaction, the insider now owns 7,275 shares of the company's stock, valued at $1,652,298. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Martin J. Gepsman sold 400 shares of the company's stock in a transaction on Monday, November 4th. The stock was sold at an average price of $222.92, for a total transaction of $89,168.00. Following the completion of the transaction, the director now owns 25,067 shares of the company's stock, valued at $5,587,935.64. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 15,621 shares of company stock worth $3,441,063. 0.30% of the stock is owned by company insiders.

CME Group Stock Performance

Shares of CME stock traded down $4.02 during trading on Wednesday, reaching $221.17. 3,663,325 shares of the company's stock traded hands, compared to its average volume of 1,918,854. The firm's 50-day moving average is $221.36 and its 200 day moving average is $209.75. The company has a market capitalization of $79.64 billion, a P/E ratio of 23.26, a PEG ratio of 5.62 and a beta of 0.55. CME Group Inc. has a 1 year low of $190.70 and a 1 year high of $230.36. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.09.

CME Group (NASDAQ:CME - Get Free Report) last posted its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.65 by $0.03. The firm had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.59 billion. CME Group had a return on equity of 13.39% and a net margin of 57.34%. During the same quarter in the prior year, the business posted $2.25 earnings per share. The business's quarterly revenue was up 18.4% on a year-over-year basis. Equities research analysts expect that CME Group Inc. will post 10.23 EPS for the current year.

CME Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, September 25th. Stockholders of record on Monday, September 9th were issued a $1.15 dividend. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.08%. The ex-dividend date was Monday, September 9th. CME Group's payout ratio is 48.37%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.